BAYLOR COLLEGE OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
A Pilot Study of Candesartan as a Treatment for Cocaine Dependence
Phase 2
Terminated
- Conditions
- Cocaine Dependence
- Interventions
- Other: Placebo with CBT
- First Posted Date
- 2013-09-10
- Last Posted Date
- 2019-09-04
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT01938664
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
Effect of Perioperative Intravenous Lidocaine on Postoperative Quality of Recovery in Patients Undergoing Spine Surgery
- First Posted Date
- 2013-08-29
- Last Posted Date
- 2015-10-01
- Lead Sponsor
- Baylor College of Medicine
- Registration Number
- NCT01930877
- Locations
- 🇺🇸
Ben Taub General Hospital, Houston, Texas, United States
Morphological Markers of Gastroesophageal Reflux Disease (GERD)
Active, not recruiting
- Conditions
- Eosinophilic EsophagitisGastroesophageal Reflux Disease
- Interventions
- Other: Sample collection and Questionnaire
- First Posted Date
- 2013-08-13
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 54
- Registration Number
- NCT01921686
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers
Not Applicable
Completed
- Conditions
- Attention Deficit Hyperactivity DisorderAttention Deficit and Disruptive Behavior Disorders
- Interventions
- Behavioral: Immediate Treatment GroupBehavioral: Delayed Treatment Group
- First Posted Date
- 2013-08-08
- Last Posted Date
- 2020-02-24
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 29
- Registration Number
- NCT01919073
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Study Examining Parker-Flex Endotracheal Tube for Obese Patients
Not Applicable
Completed
- Conditions
- Obesity
- Interventions
- Device: Portex® Tracheal TubeDevice: Parker Flex-Tip® tracheal tube
- First Posted Date
- 2013-07-10
- Last Posted Date
- 2019-09-24
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 60
- Registration Number
- NCT01894178
- Locations
- 🇺🇸
Ben Taub General Hospital, Houston, Texas, United States
Randomized Clinical Trial of Early Delivery in Fetal Gastroschisis vs. Routine Care
Not Applicable
Terminated
- Conditions
- Gastroschisis
- Interventions
- Other: Early Delivery
- First Posted Date
- 2013-06-24
- Last Posted Date
- 2017-07-13
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 21
- Registration Number
- NCT01884324
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
MER Versus MRI Guidance DBS in Parkinson's Disease
Completed
- Conditions
- Idiopathic Parkinson's Disease (PD)
- First Posted Date
- 2013-06-21
- Last Posted Date
- 2020-11-25
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 7
- Registration Number
- NCT01883973
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea
Phase 1
- Conditions
- Active C. Difficile Colitis
- Interventions
- Biological: Microbiota Transplantation (FMT)
- First Posted Date
- 2013-06-04
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 12
- Registration Number
- NCT01868373
- Locations
- 🇺🇸
Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, United States
Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A
Phase 2
Completed
- Conditions
- Hodgkin Disease
- Interventions
- Drug: ABVE-PCDrug: DECA
- First Posted Date
- 2013-05-21
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT01858922
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
Phase 1
Recruiting
- Conditions
- Acute Lymphocytic LeukemiaNon-Hodgkin LymphomaChronic Lymphocytic Leukemia
- First Posted Date
- 2013-05-15
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 64
- Registration Number
- NCT01853631
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸Houston Methodist Hospital, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath